Geographic Disparities in Access to CKD Randomized Clinical Trials in the United States.
Geographic Disparities in Access to CKD Randomized Clinical Trials in the United States. Kidney360. 2026 Sep 01.
PMID: 42678797
Acute Kidney Injury in Recipients of Chimeric Antigen Receptor T-Cell therapy: Clinical Characteristics and Impact on Mortality.
Acute Kidney Injury in Recipients of Chimeric Antigen Receptor T-Cell therapy: Clinical Characteristics and Impact on Mortality. Transplant Cell Ther. 2026 Jul 22.
PMID: 42486353
GLP-1 Agonists and Risk of Atrial Fibrillation in Non-Dialysis Chronic Kidney Disease.
GLP-1 Agonists and Risk of Atrial Fibrillation in Non-Dialysis Chronic Kidney Disease. Cardiovasc Drugs Ther. 2026 Jul 03.
PMID: 42397479
Hydrocortisone Use for Septic Shock in Patients With CKD.
Hydrocortisone Use for Septic Shock in Patients With CKD. Kidney Int Rep. 2026 Sep; 11(9):106686.
PMID: 42500310
Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients.
Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients. Hematol Oncol Stem Cell Ther. 2026 Jan-Mar 01; 19(1):10-17.
PMID: 42169662
Sepsis-Related Hospitalization and Mortality in Patients with CKD.
Sepsis-Related Hospitalization and Mortality in Patients with CKD. Clin J Am Soc Nephrol. 2026 Jan 01; 21(1):139-140.
PMID: 41082305
Left Atrial Appendage Occlusion vs Anticoagulants in Dialysis With Atrial Fibrillation.
Left Atrial Appendage Occlusion vs Anticoagulants in Dialysis With Atrial Fibrillation. JAMA Netw Open. 2025 09 02; 8(9):e2530990.
PMID: 40924421
Potent P2Y 12 Receptor Inhibitors Reduce Risk for Hospitalization from Sepsis in Patients with CKD.
Potent P2Y 12 Receptor Inhibitors Reduce Risk for Hospitalization from Sepsis in Patients with CKD. Kidney360. 2025 Nov 01; 6(11):1994-1996.
PMID: 40690307
Platelets, inflammation, and purinergic receptors in chronic kidney disease.
Platelets, inflammation, and purinergic receptors in chronic kidney disease. Kidney Int. 2024 09; 106(3):392-399.
PMID: 38821448
P2Y12 Inhibitors Refill Gap Predicts Death in Medicare Beneficiaries on Chronic Dialysis.
P2Y12 Inhibitors Refill Gap Predicts Death in Medicare Beneficiaries on Chronic Dialysis. Kidney Int Rep. 2024 Jul; 9(7):2125-2133.
PMID: 39081724